Evidence map›Paper›PMID 22499285›Full record

ArticleJournal of biomedical materials research. Part A2012

Development of a biodegradable bone cement for craniofacial applications.

Allan M Henslee, Dong-Ho Gwak, Antonios G Mikos, F Kurtis Kasper

Abstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applications.Journal of controlled release : official journal of the Controlled Release Society · 2021
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Biomaterials for tissue engineering.Annals of biomedical engineering · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Allan M HensleeDepartment of Bioengineering, Rice University, Houston, Texas 77005, USA.
Dong-Ho Gwak
Antonios G Mikos
F Kurtis Kasper

Funding

In Situ Hardening Cellular Constructs for Craniofacial Bone RegenerationR01DE017441 · NIDCR · RICE UNIVERSITY · PI MIKOS, ANTONIOS G. · 2008 to 2012
$1.6M
NIDCR NIH HHS R01 DE017441NIDCR NIH HHS R01-DE017441
6 · The paper itself

Abstract

This study investigated the formulation of a two-component biodegradable bone cement comprising the unsaturated linear polyester macromer poly(propylene fumarate) (PPF) and crosslinked PPF microparticles for use in craniofacial bone repair applications. A full factorial design was employed to evaluate the effects of formulation parameters such as particle weight percentage, particle size, and accelerator concentration on the setting and mechanical properties of crosslinked composites. It was found that the addition of crosslinked microparticles to PPF macromer significantly reduced the temperature rise upon crosslinking from 100.3°C ± 21.6°C to 102.7°C ± 49.3°C for formulations without microparticles to 28.0°C ± 2.0°C to 65.3°C ± 17.5°C for formulations with microparticles. The main effects of increasing the particle weight percentage from 25 to 50% were to significantly increase the compressive modulus by 37.7 ± 16.3 MPa, increase the compressive strength by 2.2 ± 0.5 MPa, decrease the maximum temperature by 9.5°C ± 3.7°C, and increase the setting time by 0.7 ± 0.3 min. Additionally, the main effects of increasing the particle size range from 0-150 μm to 150-300 μm were to significantly increase the compressive modulus by 31.2 ± 16.3 MPa and the compressive strength by 1.3 ± 0.5 MPa. However, the particle size range did not have a significant effect on the maximum temperature and setting time. Overall, the composites tested in this study were found to have properties suitable for further consideration in craniofacial bone repair applications.

Indexed as

Absorbable ImplantsBone CementsCompressive StrengthCross-Linking ReagentsFumaratesMaterials TestingParticle SizePolypropylenesTissue EngineeringBone CementsCross-Linking ReagentsFumaratespoly(propylene fumarate)Polypropylenes

Identifiers

PMID22499285
PMCPMC4539047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.